Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CETP | P11597 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | UBE2N | P61088 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7002279 | 0.77 | ROCK2 (0.38) | EPHX1TP53LMNAOPRM1ALDH1A1 | |
| SCHEMBL7001679 | 0.76 | — | — | |
| SCHEMBL82804 | 0.76 | — | — | |
| SCHEMBL42799 | 0.76 | — | — | |
| SCHEMBL2705159 | 0.76 | — | — | |
| Alcohol SCHEMBL8666140 | 0.74 | ALDH1A1 (0.48) | CYP2D6SPHK1TP53LMNAGMNN | |
| Hydrochloric Acid SCHEMBL18130922 | 0.74 | — | — | |
| SCHEMBL608547 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL9442918 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL1996871 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2556052-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | Sumitomo Chemical Company, Limited (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-20130035506-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-07 | — | — | US | disclosed |
| WO-2011126130-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035506-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | AADAT, BCAT2, CBS | EPHX1 2876/4885CYP2D6 2086/4885SPHK1 3216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.